Corvus' soquelitinib shows promise in oncology & autoimmune fields, with Phase 3 PTCL data as a key catalyst. Click here to ...

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares just cleared breakeven Wednesday. The South San Francisco-based company, a clinical-stage biopharmaceutical concern, today announced preclinical data ...

Rich Miller, CEO, Corvus: Thank you Roger and good morning ... today is update you on our drug development for socolitinib and ITK inhibitor, especially with our clinical results in patients ...

Golidocitinib demonstrated promising efficacy in maintaining and enhancing tumor response in peripheral T-cell lymphoma (PTCL ...

BEIJING (Reuters) -TotalEnergies will seek Mozambique's approval to lift a force majeure declaration on its $20-billion liquefied natural gas (LNG) project there and resume construction by mid ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that it will present latest clinical ...

Language-learning app Duolingo, whose CEO recently said AI would replace contract workers, has reversed course, stating that the company would "continue to hire" humans and support employees.

He’s not the first CEO to poke fun at the idea of an AI replacing a CEO. AI sales agent startup Artisan, known for its viral “stop hiring humans” ad campaign, posted an April Fool’s video ...

There are often two ways a CEO of a public company rides off into the sunset. One is when the CEO realizes they can't do more at a company and that current results are as good as they are likely ...

Cincinnati's transit agency has picked a veteran of Northern Kentucky's bus system as its new CEO. Andy Aiello will take over as Metro CEO on June 1, replacing the retiring Darryl Haley ...

CEO turnover is up, and it could get harder for some companies to find new leaders. At many companies, there has been a "collapse of the leadership pipeline," a recruiter told BI. Poor succession ...